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Modeling for biologists?
In  his  essay  ‘Can  a  biologist  fix  a  radio?’  molecular 
biologist Yuri Lazebnik highlighted the absurdity of some 
kinds  of  informal  reasoning  that  pervade  biology,  and 
called for the development of biologist-accessible (if not 
exactly  friendly)  languages  to  promote  more  formal 
approaches  to  reasoning  about  and  prediction  of  the 
behavior of molecular networks inside cells [1]. Although 
he suggested that the rise of systems biology might force 
biologists to change quickly, it is still a safe bet nearly a 
decade  later  that  most  experimental  biologists  are 
unlikely to be familiar with modeling and related software 
tools, let alone using them. This is despite the rapid rise 
of genomics and bioinformatics that has made the use of 
bioinformatics tools, such as BLAST, an essential part of 
training and practice.
I think that the development of rule-based modeling 
languages and tools, such as BioNetGen [2] and Kappa 
[3], in recent years represents a near-fulfillment of Lazeb-
nik’s  vision  of  precise  formal  modeling  languages  for 
biology,  at  least  at  the  molecular  level.  Modeling  of 
biochemical  networks  is  plagued  by  the  problem  of 
combinatorial complexity, which is the explosion in the 
number of possible species and reactions that may occur 
among molecules that have multiple components [4]. In 
conventional approaches to modeling reaction kinetics, 
such as ordinary differential equations, each species and 
reaction  must  be  explicitly  represented  in  the  model  - 
either entered into a file or drawn with a computer pro-
gram. The basic building blocks of a rule-based model, on 
the other hand, are structured objects or graphs. Various 
types of graphs are used and the general term ‘site graph’ 
has been proposed to refer to them [5]. In a site graph, 
vertices represent material components of proteins, such 
as  sites  of  binding  and  chemical  modification.  Rules, 
which are composed of site graphs, describe interactions 
among components in a precise way (Figure 1). Because 
the rule-based modeling approach is based on a graphical 
formalism, it is easy to visualize models and link formal 
model elements to the material components being repre-
sented  (Figure  1a)  [6].  The  domains  and  motifs  of  a 
signal  ing protein correspond to vertices of a site graph, 
which provides a representation of the protein analagous 
to  the  graphs  used  to  represent  atomic  structures  in 
chemistry. Rules describe the interactions among model 
elements referring only to the sites that are involved and 
without reference to sites that are not (Figure 1b). This is 
similar  to  the  way  reactions  are  described  in  organic 
chemistry,  where  the  parts  of  a  molecule  that  do  not 
participate in a reaction are left unspecified [5]. Combi-
na  torial complexity can thus be avoided in the specifi-
cation of a model as long as most interactions are local, 
that is, they involve only a few of the possible sites of the 
interacting molecules, which is a reasonable assumption 
based on current knowledge.
Because of the development of general-purpose rule-
based  languages  and  simulators,  it  is  now  possible  to 
construct biochemical models of an arbitrary number of 
network components at a high level of resolution and to 
simulate the model in a reasonable amount of time on a 
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the least of which are making the tools more accessible to 
bench biologists and, perhaps more important, fostering 
a culture in which modeling is more commonly used as a 
reasoning aid. In the near future I envision that biologists 
will be able to construct models using tools very similar 
to those that are used to search the literature and online 
knowledge  bases,  and  they  will  be  able  to  use  these 
models to predict the outcome of possible experiments 
and to gain insight into the possible mechanism through 
which the predicted effect may arise. Even researchers 
with limited mathematical or computational experience 
should be able to engage fully in the productive cycle of 
experimentation  followed  by  modeling  followed  by 
further experimentation.
To summarize up to this point, rule-based modeling 
now  provides  a  scalable  way  to  model  the  complex 
molecular  biochemistry  that  is  employed  by  cells  to 
process  information.  Incorporating  such  models  into 
every  day  study  of  signaling  systems  could  have  a  pro-
found  impact  on  molecular  biology.  So  far,  however,  I 
have considered only what goes on inside cells when they 
Figure 1. Rule-based model of early signaling events mediated by the epidermal growth factor receptor (EGFR). (a) Global view of the 
model with an Extended Contact Map (ECM) (see [7] for more detailed explanation of the notation), which shows protein components - catalytic 
domains and sites of binding and postranslational modification - and their interactions. (b) Translation of one interaction (shown in red) from the 
ECM into a reaction rule in a rule-based model. The rule indicates that a specific tyrosine residue on EGFR (Y1048) must be phosphorylated in order 
for GRB2 to bind through its SH2 domain. The absence of other components in the rule indicates that the rate of binding is not affected by the 
status of other components of either protein - in other words, this rule neglects cooperative or allosteric effects.
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Page 2 of 5are treated as well-mixed chemical bags, and not their 
internal  organization  or  how  they  interact  with  each 
other, which of course is fundamental to biology. Further-
more, a fundamental challenge in biology, to understand 
the  genetic  basis  of  phenotype,  requires  coupling 
predictive  models  of  intracellular  biochemistry  with 
models  of  higher  levels  of  organization  -  cells,  tissues, 
organs,  and  so  on  -  in  a  bi-directional  way.  Since  its 
inception,  however,  systems  biology  has  been  more 
oriented toward the molecular, intracellular level, which 
is reflected in the fact that most of the modeling tools 
that have been developed are aimed at the development 
of  chemical  network  models  and  do  not  provide 
capabilities for constructing models that span multiple 
levels of resolution. For example, standardized exchange 
formats  for  systems  biology  models,  such  as  Systems 
Biology  Markup  Language  (SBML)  [9],  do  not  readily 
support such embedding.
‘Leveling up’
Maus  et  al.  [10]  have  addressed  a  growing  need  for 
model  ing  tools  that  span  multiple  biological  levels  of 
organization  by  developing  a  multi-level  rule-based 
language, called ML-Rules. As in other rule-based lan-
guages, structured objects represent proteins and their 
components, but they may also represent higher levels of 
organization,  such  as  organelles  and  cells.  The  key 
extension in comparison to other rule-based languages is 
that objects may contain collections of other objects, and 
this  embedding  relationship  can  affect  the  behavior  of 
both container and contents (Figure 2). For example, a 
cell may contain a collection of molecules representing 
the regulatory components of the cell cycle (Figure 2a), 
and progression of the cell through the cell cycle can be 
coupled  to  the  collective  properties  of  the  cell  cycle 
network, that is, the level of active maturation promoting 
factor (MPF) (Figure 2b). This is an example of upward 
causation,  in  which  properties  of  the  lower  level 
components affect the behavior of the higher level. In the 
other direction, properties of the cell, such as its volume, 
can  affect  the  reaction  rates  of  the  enclosed  network 
(Figure 2c). This is an example of downward causation.
Both forms of causation may be concisely represented 
in ML-Rules (Figure 2b,c), allowing for the specification 
of  multi-level  models.  For  example,  a  population  of 
interacting cells may be modeled as a collection of cells, 
each  of  which  contains  a  collection  of  molecules  that 
interact via globally defined rules. The movement, growth, 
and division of cells may be defined by rules that act at 
the cell level, whereas binding, uptake, and secretion of 
molecules may be defined by rules that span the cell and 
molecular levels. The description of the intracellular level 
could be further refined by inclusion of such processes as 
endocytosis  and  nuclear  import/export,  which  would 
also require additional levels of representation for endo-
somes, nucleus, and so on.
ML-Rules  is  the  first  fully  implemented  rule-based 
model  ing language that has been described in the litera-
ture and is capable of integrating detailed molecular bio-
chemistry  into  multi-level  models.  The  hierarchical 
repre  sentation  used  in  ML-Rules  is  related  to  a  more 
general formulation called reactive bigraphs, which also 
uses  a  nested  object  hierarchy  and  reaction  rules  to 
represent  the  interactions  that  can  take  place  in  a 
complex network [11]. Several biological languages based 
Figure 2. Multi-level rule-based model of yeast cell cycle 
regulation (after [10]). (a) Nested view of the model structure. The 
world node contains a population of cells, each of which has two 
attributes, volume and cell cycle state. Stacking of boxes representing 
each entity indicates a variable number of instances. Each cell 
contains a population of molecules that comprise the biochemical 
components of the cell cycle. (b) Upward causation - components of 
the molecular layer influence dynamics of the cell layer. The number 
of MPF molecules in the I state (for ‘inactive’) controls the passage 
from G1 to S. The formula beneath the arrow must be true in order 
for the rule to fire. (c) Downward causation - the state of the cell 
influences the rate of a biochemical transformation of contained 
molecules.
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[12]), but software implementations have so far not been 
presented.
There  are,  however,  other  general-purpose  tools 
available for the integration of rule-based biochemistry, 
as described above, into multi-level models (for example, 
[13,14]).  These  tools  use  different  mathematical  and 
computational models to describe the dynamics at each 
level  of  the  system,  and  can  in  this  sense  be  termed 
‘heterogeneous’.  Of  these,  the  most  accessible  for  a 
general  audience  is  probably  the  Simmune  platform, 
which has a graphical interface that integrates all stages 
of  modeling  from  model  construction  to  data  analysis 
and allows embedding of rule-based biochemical descrip-
tions  into  cellular  agents  [14].  There  are  also  other 
general  purpose  tools  for  multi-level  modeling;  an 
example  is  CompuCell3D  [15],  which  allows  reaction 
networks described in SBML to be embedded in cellular 
simulations  of  varying  sophistication  but  cannot  yet 
handle rule-based specifications of the biochemistry.
The cell cycle example presented by Maus et al. could 
probably be implemented in each of the heterogeneous 
tools mentioned, as well as others. Each of these imple-
mentations,  however,  would  likely  be  more  difficult  to 
understand and less flexible than the corresponding ML-
Rules implementation because of the lack of a unifying 
language and adherence to a pre-defined level hierarchy. 
In most of the current frameworks, models are specified 
in the form of plain-text files and/or high-level program 
code  in  languages  such  as  Python  and  C++.  The 
embedding of levels is either fixed or achieved through 
calls to specific functions in a programming library. ML-
Rules,  on  the  other  hand,  provides  a  formal  biological 
language  for  expressing  all  parts  of  the  model.  The 
number of levels and the physical model for simulating 
each level can be achieved by refactoring the rules.
The  flexibility  of  ML-Rules  does  come  with  a  cost, 
however. Describing higher-level processes such as cell 
division with rules requires some sophistication on the 
part of the modeler; it is not simply a matter of translating 
knowledge about a specific molecular interaction into a 
rule. Such barriers could be overcome by defining rule 
templates  that  a  modeler  can  use  for  specific  types  of 
behavior and creating libraries, but it remains to be seen 
whether the heterogeneous approaches mentioned above 
or  the  unified  approach  taken  by  ML-Rules  provide  a 
better  basis  for  the  development  of  intuitive  modeling 
tools  for  the  biologist.  Simulation  efficiency  is  also  an 
issue  that  needs  to  be  addressed  before  more  realistic 
applications are possible. The stochastic simulation algo-
rithm implemented in the current version of ML-Rules is 
limited to relatively small populations of cells. Although 
no  direct  performance  comparisons  have  been  carried 
out, heterogeneous simulators, which usually have highly 
optimized simulators, are probably capable of performing 
much larger-scale simulations on the same system.
In search of the Killer App
What is needed for dynamical systems modeling of the 
type enabled by tools discussed here to take off among 
experimental  biologists?  Lowering  the  barrier  to  using 
tools and to using existing knowledge to create models is 
clearly a key requirement. At the level of molecular bio-
chemistry, rule-based modeling represents a key concep-
tual advance, although much work needs to be done to 
make it more broadly accessible. Languages for describ-
ing multi-level models are going to take more work and 
time because of the inherent complexity of the challenge, 
in terms of both representation and simulation. Finding 
the right balance of flexiblity and simplicity is difficult.
What  is  probably  more  critical  for  wider  adoption, 
however, is the demonstration that these types of models 
can lead to new discoveries that could not otherwise be 
made - a ‘Killer App’. It could take the form of a model 
that a large community of biologists adopts for the study 
of  a  specific  system  -  for  example,  yeast  pheremone 
signaling,  cell  cyle,  or  bacterial  chemotaxis.  Such  an 
example could be instrumental in convincing biologists 
to make rule-based modeling part of their standard tool-
kit for fixing radios.
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